Literature DB >> 12760873

Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of norfloxacin in rats.

Marylore Chenel1, Agnès Barbot, Antoine Dupuis, Olivier Mimoz, Joël Paquereau, Serge Bouquet, William Couet.   

Abstract

A previously developed pharmacokinetic-pharmacodynamic (PK-PD) modeling approach was used to investigate the epileptogenic activity of norfloxacin as a representative antibiotic with concentration-dependent antimicrobial activity. Rats received an intravenous infusion of norfloxacin at a rate of 5 mg kg of body weight(-1) min(-1) over 30 min. Blood samples were collected for drug assay, and an electroencephalogram (EEG) was recorded during infusion and postinfusion. An important delay was observed between concentrations of norfloxacin in plasma and the EEG effect. Indirect effect models failed to describe these data, which were successfully fitted by using an effect compartment model with a spline function to describe the relationship between effect and concentration at the effect site, as previously observed with imipenem. The robustness of the PK-PD model was then assessed by keeping the dose constant but increasing the duration of infusion to 120 and 240 min. Although this was accompanied by PK modifications, PD parameters did not vary significantly, and the PK-PD model still applied. In conclusion, the successful PK-PD modeling of the norfloxacin EEG effect in rats should be considered to predict and reduce the epileptogenic risk associated with this antibiotic as a representative fluoroquinolone (E. Fuseau and L. B. Sheiner, Clin. Pharmacol. Ther. 35:733-741, 1984).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12760873      PMCID: PMC155845          DOI: 10.1128/AAC.47.6.1952-1957.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Antagonistic interaction between the convulsant activities of pefloxacin and its main metabolite norfloxacin in rats.

Authors:  A Delon; L M Levasseur; M Giraudon; S Bouquet; W Couet
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

2.  Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.

Authors:  M R Bouw; R Xie; K Tunblad; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats.

Authors:  A Dupuis; W Couet; J Paquereau; S Debarre; A Portron; C Jamois; S Bouquet
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  Drug equilibration across the blood-brain barrier--pharmacokinetic considerations based on the microdialysis method.

Authors:  M Hammarlund-Udenaes; L K Paalzow; E C de Lange
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

5.  Simultaneous modeling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamic model.

Authors:  E Fuseau; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1984-06       Impact factor: 6.875

6.  Imipenem but not meropenem induces convulsions in DBA/2 mice, unrelated to cerebrospinal fluid concentrations.

Authors:  A Dupuis; C Pariat; P Courtois; W Couet; S Bouquet
Journal:  Fundam Clin Pharmacol       Date:  2000 Mar-Apr       Impact factor: 2.748

7.  Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats.

Authors:  A Delon; S Bouquet; F Huguet; V Brunet; P Courtois; W Couet
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

8.  Central nervous system toxicity of quinolones: human and animal findings.

Authors:  W Christ
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

Review 9.  Antibiotic-induced convulsions.

Authors:  K L Wallace
Journal:  Crit Care Clin       Date:  1997-10       Impact factor: 3.598

10.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

View more
  2 in total

1.  Norfloxacin-induced electroencephalogram alteration and seizures in rats are not triggered by enhanced levels of intracerebral glutamate.

Authors:  Marylore Chenel; Anne Limosin; Sandrine Marchand; Joël Paquereau; Olivier Mimoz; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

2.  Simultaneous central nervous system distribution and pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats.

Authors:  Marylore Chenel; Sandrine Marchand; Antoine Dupuis; Isabelle Lamarche; Joël Paquereau; Claudine Pariat; William Couet
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.